25 July 2024
Top hires for VC & PE portfolio companies Q2-2024
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Vaccine technologies | France |
| CEO | Antibody therapeutics | US |
| CEO | Interventional devices | Switzerland |
| CEO | Protein alternatives | US |
| Chief Business Officer | Immuno-oncology platform | UK |
| Chief Commercial Officer | Drug discovery services | Germany |
| Chief Financial Officer | Digital implant solutions | Switzerland |
| VP Global Sales & Marketing Strategy | Medical devices | Ireland |
| Chief Medical Officer | siRNA technology | US |
| Chief Medical Officer | Small molecule therapies | Italy |
| VP Business Development, Cell Therapy | Precision medicines | UK |
| Head of Preclinical | Monoclonal antibodies | UK |
| Head of Commercial US | Functional assays | Sweden |
| CMC Director | Peptide therapeutics | France |
| Board Directors | Small molecule biopharma | Australia |
| Scientific Operating Partner | VC investor | UK |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Medical devices | Israel |
| CEO | Antibody therapeutics | Benelux |
| Chief Commercial Officer | Computational discovery services | UK |
| Chief Financial Officer | Antibody based therapeutics | Denmark |
| Chief Scientific Officer | AI platform technologies | UK |
| Chief Technology Officer | Remote monitoring | France |
| VP Business Development | Inflammation therapeutics | UK |
| VP Global Head of Sales | Drug discovery | US |
| VP Head of R&D | Mitochondrial medicine | UK |
| Program Director | SaaS solutions for pharma | Benelux |
| Managing Partner | Life sciences consultancy services | US |
| Partner | Healthcare communications | UK |
| Chair | Protein alternatives | UK |
| Board Directors | Generics | Spain |